CytoSorbents Corporation (CTSO)

[cars100cars]

What's clear is the "beads" performed for this 9-month-old cardiac surgery post-op case. CytoSorb assisted in the recovery and provided another treatment option. The reason for the low flow rate is not discussed. Perhaps it is typical of this kind of very young patient in this very weak condition. More learning is needed with pediatric cardiac surgery patients and Dr. Chan and team are likely examining this topic. Pears, always good to see you writing and thinking about CytoSorb. "Keeping all of us on our toes," as you like to say. This case history is further evidence that CytoSorb continues on a steady path of market expansion, indications expansion and patient population expansion. As an investor in CTSO, this is one more thing to like. You can nod your head YES! now.